18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Link
http://link.springer.com/article/10.1007/s40336-018-0286-7/fulltext.html
Reference6 articles.
1. Eissa A, Ei As, Coelho RF, Rassweiler J, Davis JW, Porpiglia F, et al: The role of 68 Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of literature. Minerva Urol Nefrol 2018
2. Siva SCJ, Pryor D, Martin J, Lawrentschuk N, Hofman MS (2017) Utility of 68 Ga prostate specific membrane antigen—positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma. J Med Imaging Radiat Oncol 61:372–378
3. Demirci EOM, Kabasakal L, Decristoforo C, Talat Z, Halaç M et al (2014) 68 Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 41:1461–1462
4. Rowe SPGM, Hammers HJ, Pomper MG, Allaf ME, Javadi MS (2016) Detection of 18F-FDG PET/CT occult lesions with 18F-DCFPyL PET/CT in a patient with metastatic renal cell carcinoma. Clin Nucl Med 41:83–85
5. Sasikumar AJA, Nanabala R, Unni M, Tk P (2016) Complimentary pattern of uptake in 18F-FDG PET/CT and 68 Ga-prostate-specific membrane antigen PET/CT in a case of metastatic clear cell renal carcinoma. Clin Nucl Med 41:e517–e519
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gallium-68-Labeled Prostate-Specific Membrane Antigen (68Ga-PSMA) Uptake in Renal Cell Carcinoma and Lung Adenocarcinoma: A Case Report;Iranian Journal of Radiology;2021-10-31
2. The utility of radiolabeled PSMA ligands for tumor imaging;Chemical Biology & Drug Design;2021-09-12
3. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma;Clinical Nuclear Medicine;2020-05-12
4. The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma;European Journal of Nuclear Medicine and Molecular Imaging;2019-07-23
5. 68Ga-dotatoc vs. 18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients;Annals of Translational Medicine;2019-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3